My legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.

I do serve on various boards and I'm very honest and frank, obviously, I am a very forthright person and I do, sort of, share my candid views on anything.

My legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.

It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.

What really got me focused on cancer was when my best friend was diagnosed with breast cancer and even though she was a well-to-do person, I found that her treatment costs were crippling.

Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.

I hate the title of being called the richest woman in India, but it's the recognition that this was the value that I had created as a woman entrepreneur and that makes me very, very proud.